首页 | 本学科首页   官方微博 | 高级检索  
检索        

伐地那非在难治性ED人群中的应用
引用本文:王传航.伐地那非在难治性ED人群中的应用[J].中华男科学杂志,2006,12(4):377-380.
作者姓名:王传航
作者单位:中日友好医院男科,北京,100029
摘    要:本文回顾了高选择性口服磷酸二酯酶5(PDE5)抑制剂伐地那非在各种难治性ED人群的疗效和安全性。结果表明,伐地那非对于合并糖尿病、抑郁症、前列腺切除术后、外伤性脊髓损伤性、以及西地那非治疗无效的ED患者安全有效,为这些难治性ED人群提供了一种合理的治疗选择。

关 键 词:伐地那非  难治性ED患者
文章编号:1009-3591(2006)04-0377-04
收稿时间:2006-02-10
修稿时间:2006年2月10日

Efficacy and Safety of Vardenadil in Difficult-to-treat Erectile Dysfunction Men
WANG Chuan-hang.Efficacy and Safety of Vardenadil in Difficult-to-treat Erectile Dysfunction Men[J].National Journal of Andrology,2006,12(4):377-380.
Authors:WANG Chuan-hang
Institution:Department of Andrology, Beijing Sino-Japan Friendship Hospital, Beijing 100029, China
Abstract:This paper reviewed the efficacy and safety of vardenafil,a highly selective phosphodiesterase type 5(PDE 5) inhibitor,in men with erectile dysfunction who were difficult to treat.Several large-scale studies indicated vardenafil was effective and safe in the treatment of these difficult-to-treat ED patients,including ED with depression or diabetes,ED after radical retropubic prostatectomy,ED caused by spinal cord injury,and sildenafil nonresponders.Vardenafil provides a rational treatment alternative.
Keywords:vardenafil  difficult-to-treat erectile dysfunction patients
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号